|
89
NURSING MANAGEMENT OF PATIENTS WITH CARCINOID SYNDROME. Michelle Grover,
BSN, RN, OCN®, Sidney Kimmel Comprehensive Cancer at Johns
Hopkins Hospital, Baltimore, MD.
In order to effectively manage patients with carcinoid syndrome, oncology
nurses need to understand the precipitating factors and clinical manifestations
of this syndrome and emergency management of patients in carcinoid crisis.
Carcinoid tumors are a type of neuroendocrine tumor that produces bioactive
amines and peptides such as serotonin, growth hormone, insulin, adrenocorticotropic
hormone (ACTH), gastrin, pancreatic peptide, and calcitonin. Secretions
of these hormones causes carcinoid syndrome, which occurs in less than
10% of patients with carcinoid tumors. Carcinoid syndrome occurs when
high levels of hormones are released into the systemic circulation. The
most common manifestations of carcinoid syndrome include flushing, diarrhea,
cardiac disease, wheezing, arthralgia, changes in mental status, and skin
changes. Carcinoid syndrome is most likely to develop in patients with
liver metastases and is due to a high level of serotonin production, which
is rapidly secreted into the circulation. Carcinoid crisis is a rare but
potentially fatal manifestation of carcinoid syndrome. It has been associated
with stress, chemotherapy, anesthesia, and hepatic mass biopsies. Flushing,
diarrhea, abdominal pain, hypertension, change in mental status, and severe
hypotension can result.
A case scenario approach will be utilized to provide a review of the disease
process and pertinent nursing care issues of patients experiencing carcinoid
syndrome and crisis.
A multiple-choice post-test will be utilized to assess participants’
ability to identify important aspects of patient care.
As members of the multidisciplinary team, oncology nurses are in the unique
position to facilitate early identification of the symptoms of impending
crisis. This timely assessment leads to rapid implementation of crucial,
life-saving interventions. For this reason, oncology nurses need a working
knowledge of carcinoid tumors, syndrome, and crisis. Improved knowledge
will lead to enhanced patient education and patient outcomes, and could
potentially impact morbidity and mortality.
|